In patients with higher organ dysfunction scores ( Sepsis-related Organ Failure Assessment > 13 ) , mortality rates were significantly higher in the pyridoxalated hemoglobin polyoxyethylene group when compared with those in placebo-treated patients ( 60.9 % vs 39.2 % ; p = 0.014 ) .